Trials / Completed
CompletedNCT02930382
Assessment of Spontaneous Baroreflex Sensitivity in Carriers of Implantable Cardioverter Defibrillators: Association With Disorders of the Ventricular Heart Rate. Case-control Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Poitiers University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
We must implement 8 implantable cardioverter defibrillators (ICDs) to save a life in 3 years after myocardial infarction (MI) in primary prevention. Left ventricular ejection fraction (LVEF) is proposed as the one tool predicting sudden cardiac death after MI. Several studies have shown that impairment of spontaneous baroreflex sensitivity (BRS) after MI was predictor of sudden death.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Baroreflex assessment |
Timeline
- Start date
- 2016-05-26
- Primary completion
- 2016-05-26
- Completion
- 2016-05-26
- First posted
- 2016-10-12
- Last updated
- 2018-08-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02930382. Inclusion in this directory is not an endorsement.